A Novel Neighborhood-Based Computational Model for Potential MiRNA-Disease Association Prediction

In recent years, more and more studies have shown that miRNAs can affect a variety of biological processes. It is important for disease prevention, treatment, diagnosis, and prognosis to study the relationships between human diseases and miRNAs. However, traditional experimental methods are time-consuming and labour-intensive. Hence, in this paper, a novel neighborhood-based computational model called NBMDA is proposed for predicting potential miRNA-disease associations. Due to the fact that known miRNA-disease associations are very rare and many diseases (or miRNAs) are associated with only one or a few miRNAs (or diseases), in NBMDA, the K-nearest neighbor (KNN) method is utilized as a recommendation algorithm based on known miRNA-disease associations, miRNA functional similarity, disease semantic similarity, and Gaussian interaction profile kernel similarity for miRNAs and diseases to improve its prediction accuracy. And simulation results demonstrate that NBMDA can effectively infer miRNA-disease associations with higher accuracy compared with previous state-of-the-art methods. Moreover, independent case studies of esophageal neoplasms, breast neoplasms and colon neoplasms are further implemented, and as a result, there are 47, 48, and 48 out of the top 50 predicted miRNAs having been successfully confirmed by the previously published literatures, which also indicates that NBMDA can be utilized as a powerful tool to study the relationships between miRNAs and diseases.

[1]  Taichi Isobe,et al.  miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway , 2014, eLife.

[2]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[3]  Shijie Ma,et al.  MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma , 2015, OncoTargets and therapy.

[4]  A. Williams,et al.  Functional aspects of animal microRNAs , 2008, Cellular and Molecular Life Sciences.

[5]  Y. Akao,et al.  Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers , 2009, Oncology.

[6]  Huanqing Feng,et al.  NTSMDA: prediction of miRNA-disease associations by integrating network topological similarity. , 2016, Molecular bioSystems.

[7]  Zhijun Duan,et al.  miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression , 2014, Cell Communication and Signaling.

[8]  Haihua Gu,et al.  Abstract P5-10-06: A functional role for miR-150 in breast cancer , 2012 .

[9]  Marc Bissonnette,et al.  EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators , 2011, Molecular Cancer Research.

[10]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[11]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[12]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[13]  Zhu-Hong You,et al.  A novel computational model based on super-disease and miRNA for potential miRNA-disease association prediction. , 2017, Molecular bioSystems.

[14]  Timothy Ravasi,et al.  From link-prediction in brain connectomes and protein interactomes to the local-community-paradigm in complex networks , 2013, Scientific Reports.

[15]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[16]  Liu Ting-tin.  Serum content detection of miRNA-21 in colon cancer patients and its correlation with VEGF level , 2014 .

[17]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[18]  Xiao-ling Xu,et al.  MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. , 2014, The Annals of thoracic surgery.

[19]  Stephen R Grobmyer,et al.  Esophageal cancer—the five year survivors , 2011, Journal of surgical oncology.

[20]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[21]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[22]  J. Weidhaas,et al.  Using microRNAs to understand cancer biology. , 2010, The Lancet. Oncology.

[23]  Michael Schroeder,et al.  Pioneering topological methods for network-based drug–target prediction by exploiting a brain-network self-organization theory , 2017, Briefings Bioinform..

[24]  D. Bartel,et al.  MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.

[25]  S. Wyman,et al.  Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. , 2011, Genome research.

[26]  Lei Wang,et al.  Prediction of microRNA-disease associations based on distance correlation set , 2018, BMC Bioinformatics.

[27]  É. Várallyay,et al.  Plant virus infection-induced persistent host gene downregulation in systemically infected leaves. , 2008, The Plant journal : for cell and molecular biology.

[28]  Chen Chen,et al.  MicroRNAs in esophageal cancer (review). , 2012, Molecular medicine reports.

[29]  E. Li,et al.  MiR‐142‐3p as a potential prognostic biomarker for esophageal squamous cell carcinoma , 2012, Journal of surgical oncology.

[30]  Xu Zhang,et al.  A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network , 2018, Genes.

[31]  Yang Yuan,et al.  MicroRNA-203 inhibits cell proliferation by repressing ΔNp63 expression in human esophageal squamous cell carcinoma , 2011, BMC Cancer.

[32]  Paula K Shireman,et al.  Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis , 2009 .

[33]  Lei Wang,et al.  A Novel Probability Model for LncRNA–Disease Association Prediction Based on the Naïve Bayesian Classifier , 2018, Genes.

[34]  Kerry M Bauer,et al.  Effects of the miR-143/-145 microRNA cluster on the colon cancer proteome and transcriptome. , 2012, Journal of proteome research.

[35]  Yun Xiao,et al.  MiRNA–miRNA synergistic network: construction via co-regulating functional modules and disease miRNA topological features , 2010, Nucleic acids research.

[36]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[37]  Cheng Liang,et al.  Predicting MicroRNA-Disease Associations Using Kronecker Regularized Least Squares Based on Heterogeneous Omics Data , 2017, IEEE Access.

[38]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[39]  Zhu-Hong You,et al.  ILNCSIM: improved lncRNA functional similarity calculation model , 2016, Oncotarget.

[40]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[41]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[42]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[43]  S. Meltzer,et al.  MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. , 2009, Current opinion in pharmacology.

[44]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[45]  M. Byrom,et al.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis , 2005, Nucleic acids research.

[46]  Cheng Liang,et al.  KATZMDA: Prediction of miRNA-Disease Associations Based on KATZ Model , 2018, IEEE Access.

[47]  Hubert Rehrauer,et al.  Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. , 2011, Cancer research.

[48]  V. Ambros,et al.  MicroRNA Pathways in Flies and Worms Growth, Death, Fat, Stress, and Timing , 2003, Cell.

[49]  Xing Chen,et al.  IRWRLDA: improved random walk with restart for lncRNA-disease association prediction , 2016, Oncotarget.

[50]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[51]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[52]  Xiangxiang Zeng,et al.  Prediction of potential disease-associated microRNAs using structural perturbation method , 2017, bioRxiv.

[53]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[54]  Hailin Chen,et al.  Similarity-based methods for potential human microRNA-disease association prediction , 2013, BMC Medical Genomics.

[55]  Jian Gu,et al.  MicroRNAs in esophageal cancer , 2011 .

[56]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[57]  T. Kwok,et al.  The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. , 2009, Carcinogenesis.

[58]  Csaba Tóth,et al.  Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. , 2015, Anticancer research.

[59]  Lijing Wang,et al.  Cell-Specific Detection of miR-375 Downregulation for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma by miRNA In Situ Hybridization , 2013, PloS one.

[60]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Kassandra I. Alcaraz,et al.  Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities , 2016, CA: a cancer journal for clinicians.